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Purpose. The purpose of this study was to investigate statistical differences with MR perfusion imaging features that reflect the
dynamics of Gadolinium-uptake in MS lesions using dynamic texture parameter analysis (DTPA). Methods. We investigated 51
MS lesions (25 enhancing, 26 nonenhancing lesions) of 12 patients. Enhancing lesions (𝑛 = 25) were prestratified into enhancing
lesions with increased permeability (EL+; 𝑛 = 11) and enhancing lesions with subtle permeability (EL−; 𝑛 = 14). Histogram-
based feature maps were computed from the raw DSC-image time series and the corresponding texture parameters were analyzed
during the inflow, outflow, and reperfusion time intervals. Results. Significant differences (𝑝 < 0.05) were found between EL+ and
EL− and between EL+ and nonenhancing inactive lesions (NEL). Main effects between EL+ versus EL− and EL+ versus NEL were
observed during reperfusion (mainly in mean and standard deviation (SD): EL+ versus EL− and EL+ versus NEL), while EL− and
NEL differed only in their SD during outflow. Conclusion. DTPA allows grading enhancingMS lesions according to their perfusion
characteristics. Texture parameters of EL− were similar to NEL, while EL+ differed significantly from EL− and NEL. Dynamic
texture analysis may thus be further investigated as noninvasive endogenous marker of lesion formation and restoration.
1. Introduction
MR-based imaging biomarkers are integral parts of the diag-
nosis workup of multiple sclerosis since more than 20 years
[1]. These biomarkers include baseline MRI lesion count,
lesion load, and topography, as well as T1-associated signa-
tures of axonal damage [2]. The most common phenotype of
MS—relapsing-remitting MS—is characterized by recurrent
perivenous inflammation and demyelination of brain tissue
resulting in progressive neurological dysfunction triggered by
immunopathogenic mechanisms that are not fully explored
until now [3]. In particular, dysregulation and disruption
of the blood-brain barrier (BBB) are a critical event in the
pathological evolution of MS lesions [4]. Absence of Gd-
enhancement does not preclude BBB breakdown and vice
versa [5], although a temporal change of enhancement is
frequently considered as a surrogate marker for BBB restora-
tion. Thus, in daily clinical practice, most commonly the
tissue is thus simply characterized as “enhancing” or “nonen-
hancing” and the dynamic aspects of lesion enhancement
are frequently waived [6]. Beyond T1-weighted static MRI,
perfusion imaging offers an alternative to quantify the
amount of vascular permeability [7] and to analyze the time-
dependency of the BBB disruption [8, 9]. Since perfusion
imaging can be standardized according to the amount, flow,
and timing of Gd-administration, lesion morphology may be
reevaluated according to changes in microstructural perfu-
sion and leakage during the first pass of the bolus passage.
A recently proposed method, dynamic texture parameter
analysis (DTPA), allows investigating these spatiotemporal
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characteristics to describe specific features of enhancing and
nonenhancing lesions in MS [10]. DTPA enables a quantita-
tive grading of MS lesions and discriminates lesions accord-
ing to their statistical metrics. In this study, we aimed to
investigate whether contrast agent extravasation is associated
with characteristic metrics derived from dynamic textures
of histograms during the first pass of the perfusion and
early reperfusion. We hypothesized (i) that microstructural
perfusion analysis can be used to subcategorize enhancing
lesions according to their vascular permeability [11] and
(ii) that statistical texture analysis segregates enhancing MS
lesions by lesion-specific time-dependent patterns.
2. Materials and Methods
2.1. Patients. 12 patients (9 women, 3 men) with relapsing-
remitting MS (RR-MS, 𝑛 = 9) and secondary progressive
MS (SP-MS, 𝑛 = 3) according to the revised McDonald
criteria of 2010 [12] were included into this retrospective
analysis. The 3 SPMS patients presented with an initial
course of RRMS followed by stepwise deterioration with
superimposed relapses. Median age was 43 y (range 23–74
years). All data were derived from an ongoing prospective
study that incorporates perfusion MRI as part of the MS
imaging protocol. Inclusion criteria were (i) at least one
lesion with enhancement on T1-weighted images and (ii) at
least one lesion without enhancement on T2/FLAIR images
and normal hematocrit (0.34–0.47) [13]. The study was
approved by the local ethics committee (Cantonal Ethics
Commission Bern, Switzerland). All patients gave written
informed consent to participate in this study.
2.2. MRI Sequences and Parameters. All subjects under-
went an MRI examination with the same 3 T MRI system
(Siemens Magnetom Trio, Siemens AG, Erlangen, Germany)
equipped with a 32-channel head coil.The entireMS protocol
encompassed (i) diffusion weighted imaging (TR 6100ms,
TE 102ms, FoV read 230mm, FoV phase 100%, voxel size
1.8 × 1.8 × 4.0mm, acquisition time 1 : 45min. 19 parallel
images with a slice thickness of 4.0mm), (ii) T1-weighted
MPR pre- and postgadobutrol i.v. (TR 2530ms, TE 2.96 s,
FoV read 250mm, FoV phase 87.5%, voxel size 1.0 × 1.0
× 1.0mm, flip angle 7∘, acquisition time 4 : 30min, slices
per slab 160, and slice thickness 1.0mm), (iii) T2-weighted
imaging (TR 6580ms, TE 85ms, FoV read 220mm, FoV
phase 87.5%, voxel size 0.7 × 0.4 × 3.0mm, flip angle 150∘, and
acquisition time 6 : 03min. 42 parallel images were acquired
with a slice thickness of 3.0mm), (iv) 3D FLAIR imaging
(TR 5000ms, TE 395ms, FoV read 250mm, FoV phase 100%,
voxel size 1.0 × 1.0 × 1.0mm, and acquisition time 6 : 27min.
176 parallel images were acquired with a slice thickness of
1.0mm), and (v) T1-weighted imaging postgadobutrol i.v. (TR
297ms, TE 2.67ms, FoV read 220mm, FoV phase 87.5%,
voxel size 0.8 × 0.6 × 3.0mm, flip angle 70∘, and acquisition
time 4 : 14min. Forty-two parallel images were acquired with
a slice thickness of 3.0mm). All patients received gadobutrol
(Gadovist) 0.1mL⋅kg−1 bodyweight.The flow rate was 5mL/s,
followed by 20mL of sodium chloride with the same flow
rate. Patients were positioned comfortably in the head coil
and padding on either side of the head was used to help
immobilization.The intravenous linewith a long tubewas put
before examination to avoid unnecessary MRI table moving
during data acquisition. Perfusion analysis was performed
using DSC in addition to the standard sequences in all
patients (TR 1400ms, TE 29ms, averages 1, FoV read 230mm,
FoV phase 100%, voxel size 1.8 × 1.8 × 5.0mm, flip angle
90∘, 80 repetitions, and acquisition time 1 : 59min. 19 parallel
images were acquired with a slice thickness of 5.0mm).
2.3. Preclassification of Enhancing and Nonenhancing Lesions
for Texture Analysis. Demyelinating lesions were identi-
fied on T2-weighted and fluid attenuated inversion recov-
ery (FLAIR) MR-images. Further enhancing supratentorial
lesions were identified in the T1-weighted sequence after
Gd administration. To compare active lesions with inactive
lesions in the perfusion images, at least one supratentorial
nonenhancing lesion per patient was selected for comparison
within the same vascular territory.
2.4. Preclassification of Gd-Enhancing Lesions according to
Their Permeability. To determine the effect of leakage on
postcontrast T1-weighted MPR images, we used a commer-
cially available software (NordicIce Version 2.3; NordicNeu-
roLab AS, Bergen, Norway). We preselected enhancing MS
lesions according to their leakage coefficient K2 following
Boxerman et al. [11], a correction method in which contrast
extravasation is estimated in each voxel by determining
the voxel-wise deviation from a “nonleaky” reference tissue
response curve. K2 refers to the leakage rate detected during
DSC imaging.Themethod utilizes linear fitting to determine
the leakage coefficient, a first-order estimate of vascular
permeability proportional to the leakage, the product of
permeability, and the surface area. In short, this method
assumes that the contrast agent exhibits T2 or T2∗ effects
(“negative contrast effect”) in the intravascular compartment
but assumes that the contrast effect is mainly driven by T1-
shortening once the agent leaks into the extracellular space
(“positive contrast effect”). The K2 measured with DSC per-
fusion MR imaging reflects a combination of all these factors
on vascular leakiness. The K2 estimation has been previously
employed to investigate differences in vascular permeability
between gliomas of different grades and between primary
CNS lymphomas and glioblastoma multiforme [7, 11]. For
further texture analysis within the perfusion images, lesions
were subdivided into enhancing lesions with a detectable K2
cutoff that exceeded 0.010, indicating increased permeability
and enhancing lesions with a K2 cutoff lower than 0.010,
indicating low permeability resembling normal appearing
white matter, as suggested in a previous study of patients with
cerebral gliomas [7] (see Figure 1).
2.5. Dynamic Texture Parameter Analysis. The concept of a
texture refers to the appearance of a tissue defined by its
shape, composition, arrangement, and proportion of its ele-
mentary parts. DTPA focuses on a quantification of regional
tissue inhomogeneity according to its individual texture
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Figure 1: Prestratification of demyelinating lesions according to their leakiness. The upper row shows an enhancing lesion classified as EL+
(arrow), (a) T1w post-Gd after postprocessing with NORDIC Ice: the red area reflects the lesion with high permeability above the predefined
cutoff value of 0.01; (b) T1w post-Gd; (c) FLAIR sequence; (d) T1w pre-Gd. The lower row shows an enhancing lesion classified as EL−
(arrowhead); (e) T1wpost-Gd, after postprocessingwithNORDIC Ice: the lesionwas classified as lowpermeability lesion below the predefined
cutoff value of 0.01; (f) T1w post-Gd; (g) FLAIR sequence; (h) T1w pre-Gd.
during the bolus passage of Gd. The method uses a model-
free approach to analyzing MR texture parameter maps at
different time points between the first recorded image during
the baseline and the subsequent images during bolus passage.
The bolus passage was further divided into three epochs,
namely, the inflow, the outflow, and the reperfusion time
periods following a previous study to investigate lesion effects
and leakage on the capillary level separately for arteries and
veins [14]. The inflow and outflow time intervals are patient-
dependent; they depend on the patient cardiac health state
but also on the vascular state of the patient (e.g., stenosis).
The inflow period was in the order 2 to 3 seconds; the outflow
period was a little longer around 3–5 seconds. The baseline
period was defined as the period between the start of the
bolus injection and the time point where 2 subsequent data
points exceeded 3 standard deviations of the concentration
curve noise level. The inflow period was defined as end
of the baseline period to the peak of the concentration
time curve. The outflow period was defined as 1st time
point after the peak maximum to the first local minimum.
The recirculation period encompasses the 1st time point
after the local minimum until the last image. To facilitate
interindividual comparisons and to account for noise and
image nonuniformity due to magnetic field inhomogeneity,
a twofold normalization procedure has been performed. The
normalization consisted of (i) a normalization of the normal
appearing white matter (NAWM) in the frontal white matter
reference region to the numerical value of 1000, followed
by (ii) a normalization of the time integral of NAWM over
encompassing the inflow and outflow period which was set to
a reference value of 200. A detailed mathematical description
of the computational procedure is provided in [10].
Texture parameter maps (TPMs) were computed from
the raw DSCE-images using an in-house developed com-
puter JAVA-application. The original raw DSC EPI image
series constitutes a texture parameter map itself and was
further denoted by “TPM-ORIG.” The difference image time
series computed from TPM-ORIG were denoted by “TPM-
DIFF” and calculated by a subtraction of the first steady
state baseline image from every subsequent image during
4 BioMed Research International
Table 1: Detailed patient information.
Pt.
number
Sex Diagnosis Age
(years)
EDSS Disease duration Therapy
Acute disease
exacerbation/start
before MRI
Symptoms of acute
disease exacerbation
1 F RR-MS 56 3 29 y No No —
2 F RR-MS 44 4 First relapse 5 months ago No No —
3 F RR-MS 23 1 4.5 months No No —
4 F SP-MS 35 5 14 y No Yes/5 months Mild paresis leftleg/impaired walking
5 F RR-MS 42 4 5 months No Yes/2–5 months Tetraspasticity/urinaryurgency
6 F SP-MS 60 7.5 19 y No Yes/2 d Subacute hemiparesis left
7 F RR-MS 50 3.5 8 y Yes (interferonbeta 1b) No —
8 M SP-MS 74 7 25 y No Yes/1 d Worsening of paraparesis
9 F RR-MS 44 4 22 months No Yes/3 weeks Vertigo, weakness in rightleg, tongue sensation left
10 M RR-MS 30 1.5 12 months Yes (interferonbeta 1b) Yes/10 d
Weakness in left leg and
arm
11 M RR-MS 28 2.5 7 months No Yes/3 months Retrobulbar pain, eye lidtwinkles
12 F RR-MS 24 3 3.5 y Yes (glatirameracetate) Yes/1 month Urinary urgency/vertigo
Note: RRMS: relapsing-remitting MS, SPMS: secondary progressive MS, and EDSS: Expanded Disability Status Scale.
bolus passage. Additionally, we calculated the TPM-standard
deviation “TPM-SD” and TPM-variance “TPM-VAR” maps.
The TPM-SD and TPM-VAR maps were computed from
the TPM-DIFF map by computing pixel-by-pixel the pixels
local standard deviation and local variance for a 5 × 5 pixel
region. These maps are thus computed in the same fashion
as one would compute a moving average filtered version
of an image. The regions of interest (ROI) were manually
segregated by a board certified neuroradiologist on the raw
images and copied to the TPMs. For each TPMwe calculated
the following statistical parameters, that is, themean intensity
(“mean”), standard deviation (“SD”), variance (“VAR”), and
variance of variance (“VARVAR”). For instance, the mean
value of a regiondefined in theTPM-SDmeasures the average
local standard deviation of the TPM-DIFF-map and hence
may act as a surrogate marker for tissue heterogeneity. The
other statistical parameters (SD, VAR, etc.) are features that
measure higher order statistical properties of the TPMs.
2.6. Statistical Analysis. We used the statistical software SPSS
(IBM Corp. Released 2011. IBM SPSS Statistics for Windows,
Version 20.0. Armonk, NY: IBM Corp., USA) for the statis-
tical analysis of the acquired data. We aimed to investigate
which TPMs differentiate lesions according to severe versus
marginal leakage.
Differences between nonenhancing inactive lesions
(NEL), enhancing lesions with increased permeability (EL+),
and enhancing lesions with subtle permeability (EL−) as
determined by their K2 cutoff were analyzed. First, we
analyzed the statistical distribution of all TPM in order to be
able to select the correct test statistics. A WELCH-ANOVA
was performed for all TPM within the prestratified epochs
(baseline, inflow, outflow, and reperfusion period) due
to heteroscedasticity. For post hoc multiple comparisons
between NEL, EL+, and EL−, the Games-Howell method
was selected for all texture parameters at a given 𝑝 value of
𝑝 < 0.05 in the WELCH-ANOVA.
3. Results
The Expanded Disability Status Scale (EDSS) of the 12
patients (9 female; median age 43 y) ranged between 1 and
7.5 (mean 3.83, SD 1.95). A detailed description of the clinical
data is provided in Table 1. Nine of 12 patients were drug
naive, the remaining 3 were treated with stable dosage of
disease-modifying drugs (interferon 1b or glatiramer acetate).
Eight of 12 patients showed acute neurological symptoms,
while the remaining 4 showed none. The active lesions were
located in the deep white matter (3), juxtacortical (6), and
periventricular (16).TheNELwere selected pairwise from the
corresponding regions of the EL.
A total of 52 lesions were identified (26 EL and NEL).
One EL had to be withdrawn from final analysis due to an
equivocal Gd-uptake, resulting in 51 lesions available for final
analysis. The 25 enhancing lesions were subdivided into 11
EL+ and 14 EL− according to a K2 cutoff value of 0.01. The
BioMed Research International 5
Table 2: One-way ANOVA of the texture parameter maps (TPMs):
number of significant differences in the different time periods. A
total of 19 out of 48 (12 × 4) tests revealed statistical significant
differences.
IF OF RP Total
TPM-ORIG 0 0 2 2
TPM-DIFF 1 2 4 7
TPM-SD 0 1 4 5
TPM-VAR 0 2 3 5
Total 1 5 13 19
Note: ORIG: raw image, DIFF: difference image, SD: standard deviation,
VAR: local variance, IF: inflow, OF: outflow, and RP: reperfusion.
average lesion size in this study was 146.62mm3 (±95.82) for
NEL, 156.59mm3 (±154.29) for EL+, and 143.00mm3 (72.65)
for EL−, with no significant volume differences among the
three cohorts. The average lesion size was 9 voxels (1.8 ×
1.8 × 5mm). A multivariate analysis was performed on the
features extracted from the four texture parameter maps
(TPM-ORIG, TPM-DIFF, TPM-VAR, and TPM-SD): for this
analysis the within-lesion mean intensity (mean), standard
deviation (SD), variance (VAR), skewness, and kurtosis values
were analyzed. A one-way ANOVA with Welch correction
identified 19/48 TPM features that discriminated among the
3 lesion subtypes (Table 2).
The TPMs that appeared most sensitive to discriminate
EL+ and EL−were TPM-DIFF (7 features), followed byTPM-
SD (5 features) and TPM-VAR (5 features). The major effects
were observed during late perfusion epochs, outflow (5), and
reperfusion (13). A detailed description is provided inTable 4.
A post hoc Games-Howell test indicated significant dif-
ferences between EL+ and NEL in 8 and between EL+ and
EL− for 6 features (Table 3). The strongest discriminators
between EL+ versus NEL and EL− were observed during
reperfusion (9 features) and outflow (5 features). EL− and
NEL were discriminated exclusively by the TPM-SD during
outflow. No single test discriminated between all the three
subgroups. The results are summarized in Table 3.
4. Discussion
DTPA enables a quantitative tissue characterization of MS
lesions based on histogram-based textural features. Previous
studies investigated the feasibility of contrast-free static and
contrast-enhanced dynamic perfusion texture analyses to
differentiate EL from NEL [10, 15]. Here, we demonstrated
that EL can be further categorized into EL+ and EL− and
that EL− behave similarly to NEL by post hoc analysis of
texture parameters derived fromDSCperfusion imaging.The
dynamic texture features of EL+ and EL− correlated with the
amount of vascular permeability, reflecting predominantly
statistic differences in the local texture dynamics during
outflow and reperfusion. The texture parameter changes are
statistical measures that segregated lesions visually overall
classified as “enhancing MS plaques.” The mean contrast
differences and standard deviations of the computed texture
parameter maps were remarkably different between EL+ and
EL− and the derived features reflect the net effect of the
contrast extravasation on the dynamic signal intensity curves.
In contrast, kurtosis and skewness did not differ between
the two cohorts, indicating that only first- and second-
order moments had discriminative power and that steepness
and asymmetry of the contrast agent distribution played a
less important role in our analysis. Beyond a statistically
significant T2∗ effect caused by intralesional extravasation of
Gd during outflow and reperfusion, significantly increased
Gd concentrations and accelerated inflow were observed in
EL+ compared to NEL. Both may reflect a net inflammation-
related vasodilatation in acute and more aggressive lesions.
There was a strong similarity in the textures of EL− and
nonenhancing inactive lesions, reflecting a delayed Gd peak
concentration during venous outflow (Figure 2(a)), with only
subtle differences in the TPM-DIFF for “mean” and “SD.”
Pathological features that encompass the evolution of
acute versus subacute Gd-enhancing MS lesions have been
recently investigated by high-resolution dynamic contrast-
enhanced MRI [9]. Longitudinal enhancement dynamics of
initially nodular lesions revealed a centrifugal pattern while
older ring-like lesions enhanced centripetally with delayed
lesion filling.Thefindings indicate lesions growoutward from
a disrupted BBB along the central vein with a secondary
opening of the BBB in peripheral vessels. Later, partial
closure of BBB along the central vein and its contiguous
vessels results in a reduction of the central enhancement
and/or reduction in perfusion of the lesion core. The DTPA
features may reflect similar changes in lesion formation from
an early disruptive process continuously into the late stage
of a hypometabolic plaque. The tissue response to plaque
formation encompasses an inflammatory response and may
end up in an impaired microcirculation in late stages of EL−
and after closure of the BBB in nonenhancing inactive lesions.
Dynamic enhancement data may thus offer a time-effective
alternative for a more detailed characterization of the stages
of lesion development.
This study has limitations: We have currently not inves-
tigated longitudinal DTPA characteristics to follow whether
characteristics of EL+ turn into EL− and NEL over time,
which will be substance of subsequent investigations. We
selected a limited number of patients with RR-MS and
relapsing SP-MS that were stratified into EL+ and EL− based
on a preselection of T1 Gd-enhancing lesions according to
their vascular permeability.This enabled us to identify texture
features of lesions with high versus low- or nonpermeable
lesions. DTPA does not require a perfusion model such as
deconvolution methods or model-fitting of the bolus passage
function for quantification of theDSC image series. However,
the required normalization procedure may be affected by
local T1 effects due to increased permeability in the periven-
tricular NAWM. In order to minimize this effect, we normal-
ized the data by setting the reference region for the normal-
ization into the NAWMclose to the gray/white matter border
zone with a maximum spatial distance to the MS lesions.
DTPA features reflect statistic properties of enhancing
MS lesions beyond descriptions of “enhancement” or “no
6 BioMed Research International
Table 3: Post hoc analysis (Games-Howell test) of all 19 texture parameter maps (TPMs) that discriminated significantly between EL+, EL−,
and NEL in one-way ANOVA.
Stat. par. Time period 𝑝 values
ANOVA EL+ versus EL− EL+ versus NEL EL− versus NEL
TPM-ORIG SD RP <0.001∗ 0.018∗ 0.035∗ 0.695
TPM-ORIG VAR RP <0.001∗ 0.035∗ 0.05 0.82
TPM-DIFF Mean IF 0.02∗ 0.117 0.009∗ 0.356
TPM-DIFF Mean RP <0.001∗ 0.018∗ 0.019∗ 1
TPM-DIFF SD OF <0.001∗ 0.029∗ 0.003∗ 0.429
TPM-DIFF SD RP <0.001∗ 0.044∗ 0.030∗ 0.323
TPM-DIFF VAR OF 0.03∗ 0.084 0.030∗ 0.642
TPM-DIFF VAR RP 0.006∗ 0.248 0.231 0.254
TPM-DIFF VARVAR RP 0.039∗ 0.295 0.332 0.967
TPM-SD Mean OF <0.001∗ 0.2 0.013∗ 0.022∗
TPM-SD Mean RP <0.001∗ 0.032∗ 0.012∗ 0.063
TPM-SD SD RP 0.06∗ 0.247 0.209 0.641
TPM-SD VAR RP 0.037∗ 0.396 0.388 0.786
TPM-SD VARVAR RP 0.023∗ 0.412 0.301 0.295
TPM-VAR Mean OF 0.006∗ 0.364 0.128 0.119
TPM-VAR Mean RP 0.002∗ 0.201 0.167 0.11
TPM-VAR SD OF 0.035∗ 0.479 0.231 0.372
TPM-VAR SD RP 0.022∗ 0.353 0.331 0.385
TPM-VAR VARVAR RP 0.03∗ 0.373 0.368 0.517
Note: ORIG: raw image, DIFF: difference image, SD: standard deviation, VAR: local variance, IF: inflow, OF: outflow, RP: reperfusion, EL+: enhancing lesions
with increased permeability, EL−: enhancing lesions with subtle permeability, and NEL: nonenhancing inactive lesions; ∗𝑝 < 0.05.
enhancement” as currently used in daily routine. The tech-
nique identifies characteristic textural features that appear
during lesion evolution from severe inflammation to recov-
ery. Noteworthy, even though EL− are classified as active
lesions in daily practice, their perfusion characteristics in
terms of dynamic texture changes resemble that of NEL.
This is a novel finding in MS that motivates the incorpo-
ration of these features into machine learning approaches,
for example, into decision forest classifiers that can handle
high-dimensional input data in larger datasets. Our data
further support previous findings of tissue dependency in
microcirculation [10] that may be further extended into the
refinement and differentiation of white matter lesions other
than MS in future.
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Figure 2: The averaged temporal dynamics of NEL, EL−, and EL+ are exemplarily provided for the mean (a) and SD (b) of the DIFF-TPM.
(a) Mean of the DIFF-TPM for NEL, EL−, and EL+: the bars reflect the perfusion intensity of the lesion subtypes during baseline, inflow,
outflow, and reperfusion. Significant differences between EL+ and NEL are detected during the inflow (𝑝 = 0.009) and between EL+ and
EL− (𝑝 = 0.018) and EL+ and NEL (𝑝 = 0.019) during the reperfusion. The mean values for NEL and EL− increase until the end of the OF
with subsequent normalization to baseline during the RP. In contrast the mean values of EL+ increase only until IF, followed by a decrease
during outflow and reperfusion with negative values during reperfusion due to local leakage effects. (b) SD of the DIFF-TPM for NEL, EL−,
and EL+: the bars reflect the perfusion homogeneity of the lesion subtypes during baseline, inflow, outflow, and reperfusion. The temporal
dynamics of the EL− are similar to that of the NEL, indicating similar perfusion characteristics of EL− and NEL (n.s.). EL+ are characterized
by increasing inhomogeneity during outflow and reperfusion. The SD segregated EL+ from EL− during OF (𝑝 = 0.029) and RP (𝑝 = 0.044)
and EL+ from NEL during OF (𝑝 = 0.003) and RP (𝑝 = 0.03). The persistence of increased SD during RP indicates local leakage effects as
observed in (a).
BioMed Research International 9
Conflict of Interests
The authors declare that they have no conflict of interests.
Authors’ Contribution
Rajeev K. Verma and Johannes Slotboom contributed equally
to the study.
Acknowledgments
This study was supported by the Swiss Multiple Sclerosis
Society. The authors thank Pietro Ballinari for statistical
analysis and Manuela Wapp for paper editing.
References
[1] H. F. McFarland, J. A. Frank, P. S. Albert et al., “Using gado-
linium-enhanced magnetic resonance imaging lesions to mon-
itor disease activity in multiple sclerosis,” Annals of Neurology,
vol. 32, no. 6, pp. 758–766, 1992.
[2] J. J. Graber and S. Dhib-Jalbut, “Biomarkers of disease activity
in multiple sclerosis,” Journal of the Neurological Sciences, vol.
305, no. 1-2, pp. 1–10, 2011.
[3] B. D. Trapp, J. Peterson, R. M. Ransohoff, R. Rudick, S. Mo¨rk,
and L. Bo¨, “Axonal transection in the lesions of multiple scle-
rosis,”The New England Journal of Medicine, vol. 338, no. 5, pp.
278–285, 1998.
[4] M. I. Gaita´n, P. Sati, S. J. Inati, and D. S. Reich, “Initial inves-
tigation of the blood-brain barrier in MS lesions at 7 tesla,”
Multiple Sclerosis, vol. 19, no. 8, pp. 1068–1073, 2013.
[5] M. Filippi andM. A. Rocca, “MR imaging of multiple sclerosis,”
Radiology, vol. 259, no. 3, pp. 659–681, 2011.
[6] A. Rovira, M. Tintore´, J. C. A´lvarez-Cermen˜o, G. Izquierdo,
and J. M. Prieto, “Recommendations for using and interpreting
magnetic resonance imaging in multiple sclerosis,” Neurologia,
vol. 25, no. 4, pp. 248–265, 2010.
[7] C. H. Toh, K.-C. Wei, C.-N. Chang, S.-H. Ng, and H.-F. Wong,
“Differentiation of primary central nervous system lymphomas
and glioblastomas: comparisons of diagnostic performance of
dynamic susceptibility contrast-enhanced perfusion MR imag-
ing without and with contrast-leakage correction,” American
Journal of Neuroradiology, vol. 34, no. 6, pp. 1145–1149, 2013.
[8] Y. Lin, Y. Pan,M.Wang et al., “Blood-brain barrier permeability
is positively correlated with cerebral microvascular perfusion in
the early fluid percussion-injured brain of the rat,” Laboratory
Investigation, vol. 92, no. 11, pp. 1623–1634, 2012.
[9] M. I. Gaita´n, C. D. Shea, I. E. Evangelou et al., “Evolution of the
blood-brain barrier in newly formingmultiple sclerosis lesions,”
Annals of Neurology, vol. 70, no. 1, pp. 22–29, 2011.
[10] R.K.Verma, J. Slotboom,M.R.Heldner et al., “Characterization
of microcirculation in multiple sclerosis lesions by dynamic
texture parameter analysis (DTPA),” PLoS ONE, vol. 8, no. 7,
Article ID e67610, 2013.
[11] J. L. Boxerman, K. M. Schmainda, and R. M. Weisskoff,
“Relative cerebral blood volume maps corrected for contrast
agent extravasation significantly correlate with glioma tumor
grade, whereas uncorrected maps do not,” American Journal of
Neuroradiology, vol. 27, no. 4, pp. 859–867, 2006.
[12] C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic
criteria for multiple sclerosis: 2010 revisions to the McDonald
criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011.
[13] K. Grgac, P. C. M. van Zijl, and Q. Qin, “Hematocrit and oxy-
genation dependence of blood 1H
2
O T
1
at 7 Tesla,” Magnetic
Resonance in Medicine, vol. 70, no. 4, pp. 1153–1159, 2013.
[14] J. Slotboom, R. Schaer, C. Ozdoba et al., “A novel method for
analyzing DSCE-images with an application to tumor grading,”
Investigative Radiology, vol. 43, no. 12, pp. 843–853, 2008.
[15] O. Yu, Y. Mauss, G. Zollner, I. J. Namer, and J. Chambron,
“Distinct patterns of active andnon-active plaques using texture
analysis on brain NMR images in multiple sclerosis patients:
preliminary results,”Magnetic Resonance Imaging, vol. 17, no. 9,
pp. 1261–1267, 1999.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
